Taipei Exchange
06:00:00 2024-05-16 pm EDT
5-day change
1st Jan Change
259.5
TWD
+0.97%
+0.19%
-6.32%
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 13, 2020 at 03:28 pm EDT
Universal Vision Biotechnology Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 394.797 million compared to TWD 311.034 million a year ago. Operating income was TWD 101.109 million compared to TWD 44.997 million a year ago. Net income was TWD 89.359 million compared to TWD 46.783 million a year ago. Basic earnings per share was TWD 1.17 compared to TWD 0.61 a year ago.
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 09
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 13
CI
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024
Mar. 13
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 12
CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023
23-08-10
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-09
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-06-16
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-27
CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup
23-01-17
DJ
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-10
CI
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes
22-10-20
CI
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer
22-08-12
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-10
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-11
CI
Universal Vision Biotechnology Co., Ltd. Announces Dividend, Payable on May 13, 2022
22-03-30
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-29
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-10
CI
Universal Vision Biotechnology Co., Ltd. Announce Audit Committee Appointment
21-08-27
CI
Universal Vision Biotechnology Co., Ltd. Announces Expiration for the 4Th Term of the Remuneration Committee of the Company
21-08-27
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
21-08-10
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
21-05-11
CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend Payable on May 13, 2021
21-03-24
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
21-03-23
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
20-11-11
CI
Universal Vision Biotechnology Co., Ltd.(GTSM:3218) added to S&P Global BMI Index
20-09-21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
More about the company
Last Close Price
259.5
TWD
Average target price
305
TWD
Spread / Average Target
+17.53%
Consensus
1st Jan change
Capi.
-6.32% 683M +22.00% 43.62B +2.85% 19.34B -16.08% 2.35B +17.23% 1.96B +27.36% 1.22B -34.93% 757M -41.08% 680M +28.48% 518M +26.06% 487M
Glasses, Spectacles & Contact Lenses
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
